Mode
Text Size
Log in / Sign up

Metabolic bariatric surgery linked to lower breast cancer risk in women with obesityMetabolic bariatric surgery linked to lower breast cancer risk

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider metabolic bariatric surgery as a potential risk-reducing intervention for breast cancer in women with obesity, but await prospective confirmation.

This meta-analysis pooled data from a large cohort of adult women with obesity, comparing those who underwent metabolic bariatric surgery with those receiving non-surgical management. The primary outcome was breast cancer incidence, with secondary outcomes examining premenopausal and postmenopausal breast cancer separately. The analysis found that women who had surgery had a significantly lower incidence of breast cancer overall, with a pooled hazard ratio indicating a substantial reduction in risk. The effect was observed across both premenopausal and postmenopausal subgroups, though the report does not provide specific estimates for these secondary outcomes.

The authors emphasize that while the association is strong, the observational nature of the included studies limits the ability to establish causality. They explicitly state that further large-scale prospective studies are necessary to clarify whether the reduced risk is directly attributable to the surgery itself or to weight loss and metabolic improvements. The meta-analysis did not report on adverse events or safety outcomes, so the balance of benefits and harms cannot be fully assessed from this evidence.

For clinicians, this finding supports considering metabolic bariatric surgery as a potential strategy for reducing breast cancer risk in women with obesity, but it should be weighed against individual risks and benefits. The potential protective effect should not be overstated, and decisions should be made on a case-by-case basis, ideally within a multidisciplinary framework. Until prospective data confirm causality, this association should be viewed as hypothesis-generating rather than definitive.

For many women living with obesity, managing weight is a primary health goal. Beyond weight loss, there are concerns about how obesity impacts other serious conditions, such as breast cancer. This research looks at whether undergoing metabolic bariatric surgery (MBS) can change the risk of developing this specific type of cancer for women who are currently living with obesity.

The researchers conducted a meta-analysis, which is a study that combines and analyzes data from many different sources to find broader trends. They looked at a very large group of over 793,000 women. This group included about 140,880 women who underwent metabolic bariatric surgery and over 652,000 women who were managed without surgery. By comparing these two large groups, the researchers aimed to see if there was a measurable difference in how often breast cancer developed.

The results showed that women who had metabolic bariatric surgery had a significantly lower risk of developing breast cancer compared to those who did not have the surgery. The data indicated a reduction in risk by nearly 40 percent among those who underwent the procedure. This finding applies to both premenopausal and postmenopausal women, though the study focuses on the overall incidence of the disease across these groups.

While these results are notable, it is important to understand the limitations of this type of research. Because this was a meta-analysis rather than a single long-term trial following one group of people over many years, it shows a strong link but does not prove that the surgery is the only reason for the lower risk. Other factors, such as changes in diet or activity levels after surgery, could also play a role. The researchers noted that more large-scale prospective studies are needed to confirm exactly how and why this link exists.

For patients today, these findings suggest that metabolic bariatric surgery is associated with a lower risk of breast cancer for women with obesity. However, this study should not be used as a way to make personal medical decisions on its own. Patients should speak with their doctors to discuss how weight management and surgical options fit into their specific health needs and long-term goals.

What this means for you:
Women with obesity who had metabolic bariatric surgery showed a lower risk of breast cancer in this large analysis.

Study Details

Study typeMeta analysis
Sample sizen = 793,197
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
INTRODUCTION: Obesity is widely recognized as an important risk factor for breast cancer, largely due to its effects on hormonal regulation, chronic low-grade inflammation, and metabolic dysfunction. Metabolic bariatric surgery (MBS) produces long-term weight reduction and improves metabolic profiles, which may influence the development of obesity-related cancers. This systematic review and meta-analysis aimed to examine the relationship between bariatric surgery and breast cancer incidence in adult women with obesity. METHODS: This review followed the PRISMA reporting standards and was registered in PROSPERO. A comprehensive search of PubMed, Google Scholar, Cochrane Library, and Web of Science was performed to identify studies comparing adult underwent metabolic bariatric surgery (MBS) with those managed without surgery. Breast cancer incidence was defined as the primary outcome. Study screening, data extraction, and quality appraisal were carried out independently by multiple reviewers. Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using a random-effects model. RESULTS: Eight eligible studies involving 793,197 participants were included in the analysis. Among them, 140,880 women had undergone bariatric surgery, while 652,317 received non-surgical management. Women who underwent metabolic bariatric surgery demonstrated a significantly lower incidence of breast cancer compared with non-surgical controls (pooled HR 0.61; 95% CI 0.46-0.80). This risk reduction was observed in both premenopausal and postmenopausal populations. CONCLUSION: Among women with obesity, metabolic bariatric surgery is associated with a substantially reduced risk of developing breast cancer. While these findings suggest a potential protective effect, further large- scale prospective studies are necessary to clarify causality and identify patients who may benefit most from surgical intervention.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.